产品
  • 产品
搜索

JML PHARMTECH CO., LTD

CUSTOMER SUPPORT

Jimmylee@jmlpharm.com

CONTACT US

+(86) 595-88013521

详细内容

Abstract: Late treatment with alpha GPC for increasesing hippocampal neurogenesis and providing protection against epilepsy seizure-induced neuronal death and cognitive impairment

Choline alfoscerate (α-GPCalpha GPCL-alpha glycerylphosphorylcholineCAS No.:28319-77-9) is common choline compound and acetycholine precursor in the brain, which has been shown to be effective in the treatment of Alzheimer’s disease and dementia. α-GPC has been shown to enhance memory and cognitive function in stroke and Alzheimer’s patients but currently remains untested in patients suffering from epilepsy. This study aimed to evaluate whether α-GPC treatment after seizure can ameliorate seizure -induced cognitive impairment and neuronal injury.


The potential therapeutic effects of α-GPC on seizure-induced cognitive impairment were tested in an animal model of pilocarpine-induced seizure. Seizures were induced by intraperitoneal injection of pilocarpine (25 mg/ kg) in male rats. α-GPC (250 mg/kg) was injected into the intramuscular space once daily for one or three weeks from immediately after seizure, or from 3 weeks after the seizure onset for 3 weeks. Here we found that immediate 1-week treatment of α-GPC showed no neuroprotective effects and neurogenesis. Immediate 3-week treatment of α-GPC showed neuroprotective effect but no effect on neurogenesis. To evaluate the effect of late treatment of α-GPC on cognitive impairment following seizure, rats were injected α-GPC from 3 weeks after seizure for 3 weeks and subjected to a water maze test. In the present study, we found that administration of αGPC starting at 3 weeks after seizure improved cognitive function through reduced neuronal death and BBB disruption, and increased neurogenesis. Therefore, α-GPC injection may serve as a beneficial treatment for

improvement of cognitive function in epilepsy patients.


Reference:

Late treatment with choline alfoscerate (L-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment

Song Hee Lee, Bo Young Choi, Jin Hee Kim, A.Ra Kho, Min Sohn, Hong Ki Song,Hui Chul Choi
, Sang Won Suha
Department of Physiology, Hallym University, College of Medicine, Chuncheon, Republic of Korea
Department of Neurology, Hallym University, College of Medicine, Chuncheon, Republic of Korea

Inha University, Department of Nursing, Incheon, Republic of Korea
Hallym Institute of Epilepsy Research, Hallym University, College of Medicine, Chuncheon, Republic of Korea


JML Pharmtech is a professional alpha-GPC supplier, we can supply you alpha GPC with 99.7% up, single impurity below 0.1%, Food Grade, Pharma Grade, 100% pass 80 mesh. Please feel free to contact us for the more details.


 CONTACT US

         QUANZHOU JML PHARMTECH CO., LTD


PHONE

+86-595-88013521

+86 15860782800

LOCATION

NO.999 Quanan Rd. (M), Qingyang Street, Jinjiang, Quanzhou, Fujian 362200, China

EMAIL
Jimmylee@jmlpharm.com

技术支持: 泉州世纪通锐信息技术有限公司 | 管理登录
seo seo